TOP TIERMARKET NEWSWIRE
News & sentiment

RHYTHM PHARMACEUTICA (RYTM) — News & AI sentiment

RHYTHM PHARMACEUTICA (RYTM) news roundup. 1 story in the past week, 5 over 30 days. Average 30-day sentiment is 57/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $4.1M — net selling of $4.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 61/100
30d stories
5
avg sentiment 57/100
Insider net (90d)
$4.1M
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on RYTM

JPMorgan initiates Rhythm Pharmaceuticals stock at Overweight
Investing.com Analyst Ratings61 · neutralanalyst
3d ago
Jul 21
Jul 21
Jul 8
Jun 30
Jun 25
Jun 25
Jun 24
Jun 22
Jun 17
Jun 17
Jun 15
Jun 15
Jun 15
Jun 15
Jun 13
Jun 12
Jun 8
Jun 3
May 29
May 28
May 26
May 20
May 6
Open RYTM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →